These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9480464)

  • 1. [The evaluation of bone mineral density and selected markers of bone turnover in patients with insulin dependent diabetes mellitus].
    Miazgowski T; Andrysiak-Mamos E; Pynka S; Gulińska M; Czekalski S
    Przegl Lek; 1997; 54(7-8):533-9. PubMed ID: 9480464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 2-year follow-up study on bone mineral density and markers of bone turnover in patients with long-standing insulin-dependent diabetes mellitus.
    Miazgowski T; Czekalski S
    Osteoporos Int; 1998; 8(5):399-403. PubMed ID: 9850345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density, osteocalcin, and bone-specific alkaline phosphatase in patients with insulin-dependent diabetes mellitus.
    Lumachi F; Camozzi V; Tombolan V; Luisetto G
    Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E64-7. PubMed ID: 19751417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Decreased bone mineral density in patients with insulin-dependent-diabetes].
    Miazgowski T; Andrysiak-Mamos E; Czekalski S; Pynka S
    Pol Tyg Lek; 1995 Nov; 50(44-47):14-5, 55. PubMed ID: 8643415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
    Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
    J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures.
    Mitra D; Elvins DM; Collins AJ
    J Rheumatol; 1999 Oct; 26(10):2201-4. PubMed ID: 10529140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements.
    Akin O; Göl K; Aktürk M; Erkaya S
    Gynecol Endocrinol; 2003 Feb; 17(1):19-29. PubMed ID: 12724015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical markers of bone turnover and bone mineral density in patients with beta-thalassaemia major.
    Eren E; Yilmaz N
    Int J Clin Pract; 2005 Jan; 59(1):46-51. PubMed ID: 15707464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight.
    Viapiana O; Gatti D; Dalle Grave R; Todesco T; Rossini M; Braga V; Idolazzi L; Fracassi E; Adami S
    Bone; 2007 Apr; 40(4):1073-7. PubMed ID: 17240212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density of both genders in Type 1 diabetes according to bone composition.
    Hadjidakis DJ; Raptis AE; Sfakianakis M; Mylonakis A; Raptis SA
    J Diabetes Complications; 2006; 20(5):302-7. PubMed ID: 16949517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis.
    Chlebna-Sokol D; Rusinska A
    Endocr Regul; 2001 Dec; 35(4):201-8. PubMed ID: 11858767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes.
    Hamilton EJ; Rakic V; Davis WA; Chubb SA; Kamber N; Prince RL; Davis TM
    Diabet Med; 2009 Jan; 26(1):45-52. PubMed ID: 19125760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
    Buyukkaplan US; Akkaya A; Yildiz M; Bircan A; Aksoy Dogan A; Ozturk O
    J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density in patients with growth hormone deficiency: does a gender difference exist?
    Hitz MF; Jensen JE; Eskildsen PC
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):783-91. PubMed ID: 17121531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between bone turnover and bone density at the proximal femur in stroke patients.
    Paker N; Bugdayci D; Tekdos D; Dere C; Kaya B
    J Stroke Cerebrovasc Dis; 2009; 18(2):139-43. PubMed ID: 19251190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S; Gol M; Cimrin D; Irmak E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
    Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.